/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES
OR DISSEMINATION IN THE UNITED
STATES./
VANCOUVER, BC, Dec. 1, 2020 /CNW/ - good natured Products Inc.
(the "Company" or "good natured®") (TSX-V: GDNP), today announced
that on December 1, 2020, through a
wholly owned subsidiary, it has entered into a definitive agreement
(the "Definitive Agreement") to acquire IPF Holdings Inc. dba
Integrated Packaging Films ("IPF"), a leading rollstock sheet
extruder with over 20 years' experience, for consideration of
approximately $16.7 million (the
"Acquisition"). The Acquisition wil be satisfied by payment of
$12.5 million in cash, the issuance
of $833,467 in common shares of the
Company ("Common Shares") at a deemed price of $0.47 per Common Share, and the issuance of
a $3.3 million vendor take-back note,
subject to customary working capital adjustments. All dollar
figures in this release are in Canadian dollars unless noted
otherwise.
Founded in 1997 by the Mechar family, IPF is located in
Ayr, Ontario and is a manufacturer
of high quality, rigid plastic sheets used to create a variety of
products, including thermoformed packaging. IPF's customers serve a
diverse set of end markets, including electronics, retail,
industrial, food and medical packaging. IPF currently serves nearly
100 customers from a dedicated 32,000 square foot leased facility
on 2.9 acres of land. Customers are primarily located in the
northeast and midwest United
States and Eastern
Canada.
"Building on our 50% revenue growth year to date through
September 30, 2020, this transaction
marks another significant milestone in the Company's growth
trajectory. The Acquisition diversifies and strengthens our
industrial business group with the addition of nearly 100
customers, as well as entry into the medical and electronic
industrial rollstock segment, and contributes approximately
$17.0 million in annual sales," said
Paul Antoniadis, CEO of good
natured®. "The Acquisition of IPF strategically complements our
recent acquisition of Shepherd Thermoforming and Packaging in
May 2020 and represents good
natured®'s ability to deliver on our acquisition strategy that
underpins our organic growth business model."
Paul added: "We're delighted to welcome the Mechar family and
the entire IPF team to the good natured® team! We
share a common vision to be leaders in the development and adoption
of sustainable, planet-friendly packaging solutions in North America, so the combination of our
collective expertise, people and manufacturing capability further
positions the Company to execute against this ambition."
"We are very excited to partner with good natured®
and continue the legacy of our business that was started in 1997,"
said Bill Mechar, President and
Founder of IPF. Co-owner Mark Faber,
former CEO of CM Packaging Group, Inc. added: "Joining together
with good natured® is a strong strategic fit and will
accelerate IPF's ability to meet the growing demand for plant-based
products and broadens the product offering to our existing
thermoforming customers."
Key Highlights of the Acquisition:
- IPF generated trailing twelve-month ("TTM") revenue ending
September 2020 of approximately
$17.0 million
- Adds just under 100 business-to-business customers, growing the
Company's business to business segment to a total of approximately
500 customers
- IPF's geographic sales mix is approximately 65% US and 35%
Canadian
- Adds between $10 and $12 million (unaudited) of total assets to the
Company's balance sheet
- TTM EBITDA of approximately $3.7
million[1]
- Highly strategic and synergistic acquisition that is expected
to be immediately accretive to shareholders on an adjusted EBITDA
basis
- Expected to provide synergies of approximately $1.0 to $2.0
million in EBITDA in 2021
- Enables further vertical integration at the Company's
thermoforming facility where finished packaging gross margins are
expected to increase by 30% to 35% by incorporating roll stock
extruded at the IPF facility
- All pre-existing indebtedness of IPF will be paid out as a
deduction of purchase price proceeds
- $1.25 million in target net
working capital required at closing
- good natured® will begin recognizing revenue from IPF
commencing December 1, 2020
Key Strategic Highlights:
- Adds the medical and electronic market segments to current
industrial business group
- Establishes a full integrated custom packaging supply chain to
service eastern Canada and the
northeastern United States
- Complements and builds on the Company's existing outsourced
supply chain partnerships
- Grows customer count to approximately 500 recurring
business-to-business customers, further opening up cross-selling
opportunities
- Strengthens industrial business group innovation and new
product development pipeline
- IPF's facility includes 22 million pounds of production
capacity on an annual basis, which is being upgraded to a total
annual production capacity of 25 million pounds with an anticipated
completion date of Q1 2021. The IPF facility is currently operating
at approximately 75% capacity
Financing Details
The Company is arranging the following financing to complete the
Acquisition and related integration costs:
- $7.6 million reducing term loan
with a Canadian chartered bank with 6-year amortization at market
rates
- US$2.5 million draw down of the
BDC Capital Corp. ("BDC") acquisition line under the terms and
conditions of the Company's existing BDC credit facility, as
originally announced in June
2019
- $3.3 million 3-year vendor
take-back note at annual interest of 3.75%, the principal of which
is repayable as to 1/3 on the second anniversary of closing, with
the balance paid on the third anniversary of closing
- $833,467 in Common Shares priced
at $0.47 per Common Share issued to
one of the sellers of IPF
- $4.0 million in gross proceeds
from a bought deal private placement financing of Common Shares at
a price of $0.47 per Common Shares,
on the terms and conditions described below
The Acquisition is subject to customary closing conditions,
including TSX Venture Exchange approval.
Debt Financing Facilities from Canadian Chartered
Bank
The Company is in discussions with a Canadian chartered bank to
provide a $7.6 million reducing term
loan with a 6-year amortization. The credit facility is subject to
negotiating and settling the final credit documentation with the
bank.
In addition to the proposed $7.6
million reducing term loan credit facility to finance the
closing of the Acquisition described above, the Company expects to
obtain a $3.0 million revolving
operating line of credit, plus a $400,000 revolving capital term loan, and a
$400,000 revolving lease line. These
credit facilities will be dedicated to the IPF
operations and secured by its assets. The credit facility will be
available for use upon the closing of the Acquisition. The line of
credit will be used to fund ongoing growth of IPF through the
procurement of raw materials, inventory, and operating
requirements. All the credit facilities described in this press
release are subject to negotiating and settling the final credit
documentation with the Canadian chartered bank.
Bought Deal Private Placement of Common Shares
The Company also announced that it has entered into an agreement
with Canaccord Genuity Corp. ("Canaccord Genuity") to act as lead
underwriter and sole bookrunner pursuant to which Canaccord Genuity
has agreed to purchase, on a bought deal private placement basis,
8,520,000 Common Shares at an issue price of $0.47 per Common Share (the "Issue Price") to
raise aggregate gross proceeds of $4,004,400 (the "Offering"). The underwriting
syndicate includes Integral Wealth Securities Limited and Paradigm
Capital Inc. (all underwriting syndicate members, the
"Underwriters").
The closing of the Offering is expected to occur on or before
the date of closing of the Acquisition (the "Closing
Date").
The Company has also agreed to: (a) pay the Underwriters a cash
commission equal to 7.0% of the aggregate gross proceeds of the
Offering; (b) issue that number of broker warrants (the "Broker
Warrants") to the Underwriters equal to 7.0% of the aggregate
number of Common Shares issued pursuant to the Offering; and (c)
pay a corporate finance fee in Common Shares equal to 2.0% of the
number of Common Shares issued pursuant to the Offering. Each
Broker Warrant shall entitle the holder thereof to acquire one
Common Share at the Issue Price for a period of 24 months from the
Closing Date.
The net proceeds of the Offering are expected to be used for
completion of the Acquisition.
The Common Shares will be subject to a hold period under
applicable Canadian securities laws expiring on the date that is
four months and a day following the Closing Date.
The closing of the Offering is subject to the completion of
formal documentation, including but not limited to, the execution
of an underwriting agreement with the Underwriters in connection
with the Offering and receipt of regulatory approvals, including
approval of the TSX Venture Exchange.
This news release does not constitute an offer to sell or a
solicitation of an offer to sell any of the securities in
the United States. The securities
have not been and will not be registered under the United States
Securities Act of 1933 (the "US Securities Act") or any states
securities laws and may not be offered or sold within the United
states or to US Persons (as defined in Regulation S under the US
Securities Act) unless registered under the US Securities Act and
applicable state securities laws or an exemption from such
registration is available.
Further Details on the Acquisition
The Acquisition is an arms' length transaction. The Definitive
Agreement includes an outside date for closing of December 23, 2020 (the "Outside Date"), subject
to extension by mutual consent of the parties. The measurement time
for calculation of working capital adjustments is locked at
December 1, 2020 and the Definitive
Agreement includes a locked-box mechanic from December 1, 2020 until the Closing Date. The
purchase price will increase by a per diem of $9,516 per day between December 1, 2020 and the Closing Date. If the
closing does not occur by the Outside Date, subject to the terms
and conditions of the Definitive Agreement, the Company will be
liable for a $250,000 break fee. The
consideration shares issued under the Definitive Agreement will be
subject to a 12-month contractual hold period.
Acquisition Conference Call
To provide more details on the Company's acquisition of IPF and
related financings, the Company is pleased to host a conference
call with Paul Antoniadis, Executive
Chair & CEO, and Don Holmstrom,
Executive Vice President & CFO, on December 1, 2020 at 1:00
PM Eastern / 10:00 AM Pacific
time.
Date: December 1, 2020
Time: 1:00 PM EST / 10:00 AM PST
Toll-Free: 1-833-900-2239 International: +1 (236) 712-2470
Conference ID: 4387567
Participants are asked to dial in 10 minutes prior to the start of
the call.
A replay of the call will be available approximately two hours
after its completion through to December 15,
2020. The replay will be available by dialing 1-800-585-8367
or +1 (416) 621-4642.
The good natured® corporate profile can be found at:
investor.goodnaturedproducts.com
About good natured Products Inc.
good natured® is producing and distributing one of
North America's widest assortments
of better everyday products® made with the highest possible
percentage of renewable, plant-based materials and no BPAs,
phthalates or other chemicals of concern potentially harmful to
human health and the environment.
With a growing assortment of over 385 products and
services, good natured® creates eco-friendly home and
business products, food packaging, restaurant/take-out containers,
medical and industrial supplies designed to do good for the planet,
good for human health and good for business by driving incremental
sales, minimizing waste and reducing environmental impact, all
bundled up in a fresh and approachable brand.
For more information: goodnaturedproducts.com
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibilities for the adequacy or
accuracy of this release.
Non-GAAP financial measures
We have included in this press release certain non-GAAP
measures that are used to evaluate the performance of IPF,
including adjusted EBITDA. As non-GAAP measures generally do not
have a standardized meaning, they may not be comparable to similar
measures presented by other issuers. Adjusted EBITDA does not have
a generally accepted industry definition.
Cautionary Statement Regarding Forward-Looking Information
This press release contains "forward-looking statements"
within the meaning of applicable securities laws. Forward-looking
statements can be identified by words such as: "anticipate,"
"intend," "plan," "budget," "believe," "project," "estimate,"
"expect," "scheduled," "forecast," "strategy," "future," "likely,"
"may," "to be," "could,", "would," "should," "will" and similar
references to future periods or the negative or comparable
terminology, as well as terms usually used in the future and the
conditional. Examples of forward-looking statements include, among
others, the expected closing of the Acquisition, the availability
of debt and equity financing for the Acquisition, statements
regarding the Offering including the amount to be raised, and the
projected impact of completion of the Acquisition on the Company's
business, financial conditions and results.
By their nature, forward-looking statements involve known and
unknown risks, uncertainties, changes in circumstances and other
factors that are difficult to predict and many of which are outside
of the Company's control which may cause our actual results,
performance or achievements, or other future events, to be
materially different from any future results, performance or
achievements expressed or implied by such forward-looking
statements.
Forward-looking statements are neither historical facts nor
assurances of future performance. Instead, they are based only on
the Company's current beliefs, expectations and assumptions
regarding the future of its business, future plans and strategies,
projections, anticipated events and trends, general market
conditions, the economy and other future conditions. The Company's
actual results and financial condition may differ materially from
those indicated in the forward-looking statements. Therefore, you
should not rely on any of these forward-looking statements.
Important factors that could cause actual results and financial
conditions to differ materially from those indicated in the
forward-looking statements include, among others:
- The risk that the closing conditions for completion of the
Acquisition are not satisfied, including due to lack of
financing.
- Risks relating to general economic, market and business
conditions.
- Unforeseen delays in the timelines for any of the
transactions or events described in this press release.
The Company considers its assumptions to be reasonable based
on currently available information, but cautions the reader that
Its assumptions regarding future events, many of which are beyond
the control of the Company, may ultimately prove to be incorrect
since they are subject to risks and uncertainties that affect the
Company and its businesses. When relying on the Company's
forward-looking statements and information to make decisions,
investors and others should carefully consider the foregoing
factors and other uncertainties and potential events. The Company
has assumed that the material factors referred to above will not
cause such forward-looking statements and information to differ
materially from actual results or events. However, there can be no
assurance that such assumptions will reflect the actual outcome of
such items or factors.
Other than as required under securities laws, the Company
does not undertake to update this information at any particular
time.
Forward-looking statements contained in this news release are
based on the Company's current estimates, expectations and
projections regarding, among other things, sales volume and pricing
which it believes are reasonable as of the current date. The reader
should not place undue importance on forward-looking statements and
should not rely upon these statements as of any other date. All
forward-looking statements contained in this news release are
expressly qualified in their entirety by this cautionary
statement.
_______________________________________
|
1 TTM
EBITDA is a non-GAAP financial measure and does not have any
standardized meaning prescribed by IFRS-IASB. See 'Non-GAAP
financial measures' in this news release
|
SOURCE Good Natured Products